Hormonal contraception and cardiovascular system.

Arq Bras Cardiol

Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, SP, Brazil.

Published: April 2011

AI Article Synopsis

  • Hormonal contraception is the most popular method for preventing unplanned pregnancies but is linked to cardiovascular risks.
  • The review examines the impact of hormonal contraceptives on conditions like arterial and venous thrombosis and high blood pressure, which are rising in prevalence among young women.
  • The goal is to provide better guidelines for contraceptive use in women with cardiovascular risk factors.

Article Abstract

Hormonal contraception is the most widely used method to prevent unplanned pregnancies. The literature has shown an association between cardiovascular risk and use of hormone therapy. With the purpose of providing better guidelines on contraception methods for women with risk factors for cardiovascular disease, we have reviewed the literature on the subject. This review describes the latest data from the scientific literature concerning the influence of hormonal contraceptives on arterial thrombosis, venous thrombosis and systemic high blood pressure, which are diseases that have become increasingly prevalent among young females.

Download full-text PDF

Source
http://dx.doi.org/10.1590/s0066-782x2011005000022DOI Listing

Publication Analysis

Top Keywords

hormonal contraception
8
contraception cardiovascular
4
cardiovascular system
4
system hormonal
4
contraception method
4
method prevent
4
prevent unplanned
4
unplanned pregnancies
4
pregnancies literature
4
literature association
4

Similar Publications

CDK2 plays a pivotal role in controlling the cell cycle progression in eukaryotes and for this reason, it has been the subject of several studies for suitable inhibitors in the last decades. But more than 30 years of basic research have not generated an inhibitor as marketed drugs. Some inhibitors are to date in early phase clinical development.

View Article and Find Full Text PDF

Background: Whether pathophysiological factors differ between males and females with irritable bowel syndrome-diarrhea (IBS-D) remains to be tested. To better understand potential sex differences, males with IBS-D were compared to naturally cycling females and to females with IBS-D taking hormonal contraception on plasma levels of cytokines and gut microbiome characteristics.

Methods: Males and females with Rome III IBS-D completed questionnaires and kept a daily symptom diary for 28 days.

View Article and Find Full Text PDF

Contraception Update: A Focus on Safety and Efficacy.

J Womens Health (Larchmt)

January 2025

Obstetrics and Gynecology Institute, Cleveland Clinic, Cleveland, Ohio, USA.

This clinical update serves as a brief summary of recently published and potentially practice changing journal articles. We review recent publications related to contraceptive safety and efficacy. The article discusses updated medical eligibility recommendations, effectiveness of progestin-only pills (including the newly approved over-the-counter pill), safety of estrogen containing contraceptives in those with migraine, topiramate interactions with hormonal contraception, and the use of nonsteroidal antiinflammatory drugs (NSAIDs) with oral emergency contraception to improve efficacy.

View Article and Find Full Text PDF

Background: Previous research has shown that females who use hormonal contraception are at increased risk of developing depression, and that the risk is highest among adolescents. While this finding could reflect age-specific effects of exogenous hormones on mental health, genetic liability for mental disorders could be confounding the association. Our goal was to test the plausibility of this hypothesis by determining whether polygenic liabilities for major depressive disorder (MDD), bipolar disorder (BD), schizophrenia (SCZ), and attention deficit hyperactivity disorder (ADHD) are associated with younger age at hormonal contraception initiation.

View Article and Find Full Text PDF

Testing the efficacy of hormonal male contraception: A step in the right direction.

Fertil Steril

December 2024

Desai Sethi Urology Institute, University of Miami Miller School of Medicine; The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine. Electronic address:

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!